About the Study
A clinical research study is being conducted to evaluate an investigational medication in individuals diagnosed with Dravet syndrome. Dravet syndrome is a rare, severe epilepsy often associated with mutations in the SCN1A gene and characterized by multiple seizure types.
The purpose of this study is to better understand the safety and potential effects of the investigational medication. Participation in this study is completely voluntary. Compensation may be provided for eligible participants. Your participation could help advance understanding and improve future treatment options for Dravet Syndrome.
Who may qualify:










